Approval · Notice of Compliance 21517 · 2018
REVOLUTION PLUS: Notice of Compliance 21517
Issued November 6, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21517
- Date
- November 6, 2018
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVOLUTION PLUS | 02482266 | Marketed |
Medicinal ingredients
- SELAMECTIN 60 MG per ML
- SAROLANER 10 MG per ML